US Stock MarketDetailed Quotes
TSBX Turnstone Biologics
- 0.519
- +0.014+2.73%
Close Nov 29 13:00 ET
- 0.510
- -0.009-1.70%
Post 13:18 ET
12.00MMarket Cap-161P/E (TTM)
0.525High0.500Low22.30KVolume0.510Open0.505Pre Close11.41KTurnover0.16%Turnover RatioLossP/E (Static)23.13MShares5.75052wk High0.27P/B7.31MFloat Cap0.43952wk Low--Dividend TTM14.09MShs Float13.200Historical High--Div YieldTTM4.95%Amplitude0.439Historical Low0.511Avg Price1Lot Size
Turnstone Biologics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | -73.66%19.31M | 0 | 0 | 0 | 80.13%19.31M | -27.64%73.3M | 10.45M |
| Operating revenue | --0 | --0 | --0 | -73.66%19.31M | --0 | --0 | --0 | 80.13%19.31M | -27.64%73.3M | --10.45M |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -2.97%18.37M | 0.94%22.06M | 5.03%20.69M | -25.34%78.34M | -27.32%17.86M | -28.54%18.93M | -28.28%21.85M | -15.81%19.7M | 53.63%104.93M | 24.57M |
| Selling and administrative expenses | -17.11%3.94M | -7.13%4.33M | 21.55%4.9M | -2.06%17.85M | 1.03%4.4M | -9.20%4.76M | 18.49%4.66M | -14.18%4.03M | 34.53%18.22M | --4.35M |
| -General and administrative expense | -17.11%3.94M | -7.13%4.33M | 21.55%4.9M | -2.06%17.85M | 1.03%4.4M | -9.20%4.76M | 18.49%4.66M | -14.18%4.03M | 34.53%18.22M | --4.35M |
| Research and development costs | 1.78%14.42M | 3.12%17.73M | 0.78%15.79M | -30.23%60.49M | -33.42%13.46M | -33.31%14.17M | -35.21%17.19M | -16.22%15.67M | 58.35%86.7M | --20.21M |
| Operating profit | 2.97%-18.37M | -0.94%-22.06M | -5,151.52%-20.69M | -86.66%-59.03M | -26.46%-17.86M | -16.34%-18.93M | -290.91%-21.85M | 96.89%-394K | -195.86%-31.63M | -14.12M |
| Net non-operating interest income expense | ||||||||||
| Other net income (expense) | -67.05%520K | 117.58%755K | 183.68%1.08M | 280.06%3.55M | 165.17%1.24M | 689.00%1.58M | 92.78%347K | 347.06%380K | 31.78%933K | 468K |
| Other non- operating income (expenses) | -67.05%520K | 117.58%755K | 183.68%1.08M | 280.06%3.55M | 165.17%1.24M | 689.00%1.58M | 92.78%347K | 347.06%380K | 31.78%933K | --468K |
| Income before tax | -2.86%-17.85M | 0.94%-21.3M | -139,992.86%-19.61M | -80.78%-55.49M | -21.70%-16.62M | -7.97%-17.35M | -284.97%-21.51M | 99.89%-14K | -191.07%-30.69M | -13.65M |
| Income tax | -2,372.73%-816K | 133.33%2K | 119.51%16K | -302.84%-286K | -1,200.00%-165K | -141.25%-33K | -123.08%-6K | -510.00%-82K | -67.36%141K | 15K |
| Net income | 1.66%-17.03M | 0.91%-21.3M | -28,966.18%-19.63M | -79.02%-55.2M | -20.36%-16.45M | -7.23%-17.32M | -285.34%-21.5M | 100.54%68K | -192.68%-30.83M | -13.67M |
| Net income continuous Operations | 1.66%-17.03M | 0.91%-21.3M | -28,966.18%-19.63M | -79.02%-55.2M | -20.36%-16.45M | -7.23%-17.32M | -285.34%-21.5M | 100.54%68K | -192.68%-30.83M | ---13.67M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 1.66%-17.03M | 0.91%-21.3M | -28,966.18%-19.63M | -79.02%-55.2M | -20.36%-16.45M | -7.23%-17.32M | -285.34%-21.5M | 100.54%68K | -192.68%-30.83M | -13.67M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | 0 | 0 | 0 | 68K | ||||||
| Net income attributable to common stockholders | 1.66%-17.03M | 0.91%-21.3M | -19.63M | -79.02%-55.2M | -20.08%-16.41M | -7.23%-17.32M | -285.34%-21.5M | 0 | -192.68%-30.83M | -13.67M |
| Basic earnings per share | 26.00%-0.74 | 5.05%-0.92 | -0.85 | -243.98%-4.78 | -18.52%-0.73 | -37.38%-1 | -285.34%-0.9689 | 0 | -192.68%-1.3896 | -0.6159 |
| Diluted earnings per share | 26.00%-0.74 | 5.05%-0.92 | -0.85 | -243.98%-4.78 | -18.52%-0.73 | -37.38%-1 | -285.34%-0.9689 | 0 | -192.68%-1.3896 | -0.6159 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data